Mesa Laboratories Inc
NASDAQ:MLAB

Watchlist Manager
Mesa Laboratories Inc Logo
Mesa Laboratories Inc
NASDAQ:MLAB
Watchlist
Price: 116.45 USD 2.49%
Market Cap: 632.3m USD
Have any thoughts about
Mesa Laboratories Inc?
Write Note

Mesa Laboratories Inc
Total Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Mesa Laboratories Inc
Total Current Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
Mesa Laboratories Inc
NASDAQ:MLAB
Total Current Assets
$108m
CAGR 3-Years
-30%
CAGR 5-Years
-17%
CAGR 10-Years
13%
Becton Dickinson and Co
NYSE:BDX
Total Current Assets
$10.5B
CAGR 3-Years
6%
CAGR 5-Years
9%
CAGR 10-Years
5%
Boston Scientific Corp
NYSE:BSX
Total Current Assets
$8.8B
CAGR 3-Years
12%
CAGR 5-Years
13%
CAGR 10-Years
11%
Stryker Corp
NYSE:SYK
Total Current Assets
$14.7B
CAGR 3-Years
16%
CAGR 5-Years
11%
CAGR 10-Years
5%
Abbott Laboratories
NYSE:ABT
Total Current Assets
$23.1B
CAGR 3-Years
-1%
CAGR 5-Years
7%
CAGR 10-Years
3%
Intuitive Surgical Inc
NASDAQ:ISRG
Total Current Assets
$7.2B
CAGR 3-Years
8%
CAGR 5-Years
11%
CAGR 10-Years
16%
No Stocks Found

Mesa Laboratories Inc
Glance View

Market Cap
631.1m USD
Industry
Health Care

Mesa Laboratories, Inc. engages in the design, manufacture, and market of instruments and disposable products utilized in healthcare, pharmaceutical, food and beverage, medical device, and petrochemical industries. The company is headquartered in Lakewood, Colorado and currently employs 506 full-time employees. The firm operates through four segments, Sterilization and Disinfection Control, Biopharmaceutical Development, Instruments, and Continuous Monitoring. The Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators which are used to assess the effectiveness of sterilization and disinfection processes in the hospital, medical device, and pharmaceutical industries. The Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Instruments segment designs, manufactures, and markets quality control hardware and disposable products. The Continuous Monitoring segment develops, and markets systems which are used to monitor various environmental parameters such as temperature, humidity, and differential pressure.

MLAB Intrinsic Value
120.98 USD
Undervaluation 4%
Intrinsic Value
Price

See Also

What is Mesa Laboratories Inc's Total Current Assets?
Total Current Assets
108m USD

Based on the financial report for Sep 30, 2024, Mesa Laboratories Inc's Total Current Assets amounts to 108m USD.

What is Mesa Laboratories Inc's Total Current Assets growth rate?
Total Current Assets CAGR 10Y
13%

Over the last year, the Total Current Assets growth was -8%. The average annual Total Current Assets growth rates for Mesa Laboratories Inc have been -30% over the past three years , -17% over the past five years , and 13% over the past ten years .

Back to Top